Intrinsic Value of S&P & Nasdaq Contact Us

Omega Healthcare Investors, Inc. OHI NYSE

NYSE • Real Estate • REIT - Healthcare Facilities • US • USD

SharesGrow Score
71/100
3/7 Pass
SharesGrow Intrinsic Value
$41.95
-7.9%
Analyst Price Target
$49.14
+7.9%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Omega Healthcare Investors, Inc. (OHI) trades at a trailing P/E of 22.8, forward P/E of 22.8. Trailing earnings yield is 4.39%, forward earnings yield 4.39%. PEG 0.90 (Peter Lynch undervalued ≤1.0). Graham Number is $28.68.

Criteria proven by this page:

  • VALUE (40/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
  • Forward P/E 22.8 (down from trailing 22.8) — analysts expect earnings to grow, which would improve the valuation.
  • PEG Ratio 0.90 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield 4.39% — roughly competitive with bond yields (~4.3%), moderate risk-reward.
  • Analyst consensus target $49.14 (+7.9% upside) — modest upside expected.

Overall SharesGrow Score: 71/100 with 3/7 criteria passed.

SharesGrow 7-Criteria Score
71/100
SG Score
View full scorecard →
~
VALUE
40/100
Price-to-Earnings & upside
Proven by this page
~
FUTURE
40/100
Analyst consensus
→ Forecast
PAST
100/100
→ Income
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
58/100
→ Income
GROWTH
90/100
→ Income
INCOME
100/100
→ Income

Valuation Snapshot — OHI

Valuation Multiples
P/E (TTM)22.8
Forward P/E22.8
PEG Ratio0.90
Forward PEG7.35
P/B Ratio2.60
P/S Ratio11.25
EV/EBITDA15.1
Per Share Data
EPS (TTM)$1.99
Forward EPS (Est.)$2.00
Book Value / Share$18.36
Revenue / Share$4.02
FCF / Share$2.90
Yields & Fair Value
Earnings Yield4.39%
Forward Earnings Yield4.39%
Dividend Yield5.90%
Graham Number$28.68
SharesGrow IV$41.95 (-7.9%)
Analyst Target$49.14 (+7.9%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 16.4 0.35 1.55 6.66 7.56%
2017 54.2 -0.74 1.53 5.99 9.23%
2018 25.0 0.14 2.04 7.98 7.51%
2019 26.5 1.97 2.19 9.73 6.24%
2020 51.9 -0.92 2.15 9.27 7.40%
2021 16.8 0.11 1.79 6.60 9.10%
2022 15.5 5.44 1.83 7.52 9.58%
2023 30.4 -0.69 2.06 7.76 8.73%
2024 24.0 0.43 2.15 9.29 7.02%
2025 22.2 0.78 2.53 10.96 5.94%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $1.90 $900.83M $366.42M 40.7%
2017 $0.51 $908.39M $100.42M 11.1%
2018 $1.34 $881.68M $281.58M 31.9%
2019 $1.54 $928.83M $341.12M 36.7%
2020 $0.68 $892.38M $159.33M 17.9%
2021 $1.71 $1.06B $416.74M 39.2%
2022 $1.75 $878.24M $426.93M 48.6%
2023 $1.00 $949.74M $242.18M 25.5%
2024 $1.55 $1.05B $406.33M 38.6%
2025 $1.94 $1.2B $590.11M 49.3%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $2.00 $1.96 – $2.03 $1.08B $1.04B – $1.15B 4
2027 $2.06 $2.02 – $2.08 $1.14B $1.1B – $1.22B 4
2028 $2.05 $1.66 – $2.88 $1.19B $1.18B – $1.19B 4
2029 $1.95 $1.86 – $2.12 $1.19B $1.15B – $1.27B 2
2030 $0.00 $0.00 – $0.00 $1.14B $1.1B – $1.22B 2
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message